41st week of 2016 patent applcation highlights part 8 |
Patent application number | Title | Published |
20160296497 | 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | 2016-10-13 |
20160296498 | Ketorolac Sublingual Spray Formulations | 2016-10-13 |
20160296499 | Spiroindoline Antiparasitic Derivatives | 2016-10-13 |
20160296500 | TACROLIMUS FOR USE IN TREATING DISEASES CHARACTERIZED BY PROTEIN AGGREGATE DEPOSITION IN NEURONAL CELLS | 2016-10-13 |
20160296501 | P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS | 2016-10-13 |
20160296502 | ANTIBACTERIAL COMPOSITIONS | 2016-10-13 |
20160296503 | NOVEL QUINUCLIDINE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME | 2016-10-13 |
20160296504 | METHODS AND COMPOSITIONS FOR TREATING NEPHROGENIC DIABETES INSIPIDUS | 2016-10-13 |
20160296505 | THERAPEUTIC DRUG FOR DISEASES RELATED TO ENDOPLASMIC RETICULUM CELL DEATH IN CORNEAL ENDOTHELIUM | 2016-10-13 |
20160296506 | Methods and Compositions for Treating HIV Infection | 2016-10-13 |
20160296507 | IMIDAZOPYRIDINE, IMIDAZOPYRIMIDINE AND IMIDAZOPYRAZINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS | 2016-10-13 |
20160296508 | CCR6 COMPUNDS | 2016-10-13 |
20160296509 | NOVEL QUINOLINE DERIVATIVES AND THEIR USE IN NEURODEGENERATIVE DISEASES | 2016-10-13 |
20160296510 | LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON | 2016-10-13 |
20160296511 | LAQUINIMOD FOR REDUCING THALAMIC DAMAGE IN MULTIPLE SCLEROSIS | 2016-10-13 |
20160296512 | TREATMENT OF CROHN'S DISEASE WITH LAQUINIMOD | 2016-10-13 |
20160296513 | TREATMENT OF MULTIPLE SCLEROSIS BY ALEMTUZUMAB INDUCTION FOLLOWED BY LAQUINIMOD THERAPY | 2016-10-13 |
20160296514 | PHARMACOLOGICALLY ACTIVE COMPOUNDS | 2016-10-13 |
20160296515 | NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | 2016-10-13 |
20160296517 | AZAINDAZOLE COMPOUNDS AND METHODS OF USE | 2016-10-13 |
20160296518 | INDOLES | 2016-10-13 |
20160296519 | PREVENTION OF HIV-INFECTION | 2016-10-13 |
20160296520 | COMBINATION THERAPY | 2016-10-13 |
20160296521 | INHIBITORS OF HSV NUCLEOTIDYL TRANSFERASES AND USES THEREFOR | 2016-10-13 |
20160296522 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | 2016-10-13 |
20160296523 | Sirtuin Modulators as Inhibitors of Cytomegalovirus | 2016-10-13 |
20160296524 | IRAK INHIBITORS AND USES THEREOF | 2016-10-13 |
20160296525 | AMINOQUINAZOLINE AND PYRIDOPYRIMIDINE DERIVATIVES | 2016-10-13 |
20160296526 | TRICYCLIC COMPOUNDS AS MODULATORS OF TNF-ALPHA SYNTHESIS AND AS PDE4 INHIBITORS | 2016-10-13 |
20160296527 | HIV PROTEASE INHIBITORS | 2016-10-13 |
20160296528 | MACROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS | 2016-10-13 |
20160296529 | AMINOTRIAZOLOPYRIDINE FOR USE IN THE TREATMENT OF INFLAMMATION, AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2016-10-13 |
20160296530 | NOVEL COMPOUND USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES | 2016-10-13 |
20160296531 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | 2016-10-13 |
20160296532 | Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent | 2016-10-13 |
20160296533 | LIBIDO-ENHANCING THERAPEUTIC AND USE | 2016-10-13 |
20160296534 | PROGESTERONE RECEPTOR ANTAGONIST DOSAGE FORM | 2016-10-13 |
20160296535 | TRANSDERMAL DRUG DELIVERY SYSTEMS FOR LEVONORGESTREL AND ETHINYL ESTRADIOL | 2016-10-13 |
20160296536 | Administration of Glucocorticoid Steroids to Livestock | 2016-10-13 |
20160296537 | Pharmaceutical Compositions for Minocycline | 2016-10-13 |
20160296538 | PREDICTIVE AND RESPONSE BIOMARKER FOR TH-302 ANTI-CANCER THERAPY | 2016-10-13 |
20160296539 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2016-10-13 |
20160296540 | COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF NECROTIZING ENTEROCOLITIS IN INFANTS AND YOUNG CHILDREN | 2016-10-13 |
20160296541 | COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF NECROTIZING ENTEROCOLITIS IN INFANTS AND YOUNG CHILDREN | 2016-10-13 |
20160296542 | COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF NECROTIZING ENTEROCOLITIS IN INFANTS OR YOUNG CHILDREN BORN BY C-SECTION | 2016-10-13 |
20160296543 | COMPOSITIONS FOR PREVENTING OR TREATING ALLERGIES IN INFANTS FROM OR FED BY NON SECRETOR MOTHERS BY PROVIDING FUCOSYLATED-OLIGOSACCHARIDES IN PARTICULAR AMONG INFANTS AT RISK OR BORN BY C-SECTION | 2016-10-13 |
20160296544 | METHODS FOR PREVENTING OR MITIGATING ACUTE ALLERGIC RESPONSES USING HUMAN MILK OLIGOSACCHARIDES | 2016-10-13 |
20160296545 | METHOD FOR TREATING A CANCER | 2016-10-13 |
20160296546 | SOLID FORMS COMPRISING 4-AMINO-I-B-D-RIBOFURANOSYL-1,3,5-TRIAZIN-2 (1H) -ONE AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF | 2016-10-13 |
20160296547 | COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 | 2016-10-13 |
20160296548 | METHODS FOR TREATING CANCER | 2016-10-13 |
20160296549 | PHARMACEUTICAL FORMULATIONS COMPRISING HIGH PURITY CANGRELOR AND METHODS FOR PREPARING AND USING THE SAME | 2016-10-13 |
20160296550 | Methods for Treating or Preventing Ophthalmological Conditions | 2016-10-13 |
20160296551 | POLYINOSINIC-POLYCYTIDYLIC ACID (POLY (I:C)) FORMULATIONS FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS | 2016-10-13 |
20160296552 | Treating Bacterial Infections of the Lung | 2016-10-13 |
20160296553 | STRESS MANAGEMENT IN LIVESTOCK | 2016-10-13 |
20160296554 | PREVENTION AND TREATMENT OF TOXICOSIS | 2016-10-13 |
20160296555 | COMBINATION OF PYRIDOXINE, FOLIC ACID AND MAGNESIUM IONS FOR TREATING CANCER | 2016-10-13 |
20160296556 | INHIBITORS OF ERCC1-XPF AND METHODS OF USING THE SAME | 2016-10-13 |
20160296557 | METHOD | 2016-10-13 |
20160296558 | ADSORBENT FOR REDUCING UREMIC TOXINS IN VIVO | 2016-10-13 |
20160296559 | METHOD FOR TREATING PANCREATITIS WITH MESENCHYMAL STEM CELLS | 2016-10-13 |
20160296560 | A METHOD OF PRODUCING EXOSOMES | 2016-10-13 |
20160296561 | REGULATORY MACROPHAGES AS A CELL-BASED IMMUNOMODULATORY THERAPY IN PULMONARY HYPERTENSION AND RIGHT VENTRICULAR DYSFUNCTION | 2016-10-13 |
20160296562 | CELL | 2016-10-13 |
20160296563 | METHOD FOR GENERATING BATCHES OF ALLOGENEIC T-CELLS WITH AVERAGED POTENCY | 2016-10-13 |
20160296564 | Modified Natural Killer T Cells, Pharmaceutical Compositions and Uses Thereof | 2016-10-13 |
20160296565 | TOLERIZING TREATMENTS FOR AUTOIMMUNE DISEASE | 2016-10-13 |
20160296566 | ENZYME-TREATED BOVINE COLOSTRUM, PREPARATION METHOD THEREOF, COMPOSITION, AND FOODS AND BEVERAGES | 2016-10-13 |
20160296567 | Pharmaceutical composition for the prophylaxis and/or treatment of diseases in which LPS- and/or apoptosis regulation is disturbed | 2016-10-13 |
20160296568 | COMPOSITIONS FOR FECAL FLORAL TRANSPLANTATION AND METHODS FOR MAKING AND USING THEM AND DEVICES FOR DELIVERING THEM | 2016-10-13 |
20160296569 | USE OF A COMPOSITION COMPRISING MICROORGANISMS TO INCREASE THE INTESTINAL PRODUCTION OF BUTYRIC ACID, FOLIC ACID OR NIACIN AND/OR DECREASE THE INTESTINAL PRODUCTION OF SUCCINIC ACID | 2016-10-13 |
20160296570 | LACTOBACILLUS PLANTARUM INDUCIA DSM 21379 AS ENHANCER OF CELLULAR IMMUNITY, HYPOCHOLESTEROLEMIC AND ANTI-OXIDATIVE AGENT AND ANTIMICROBIAL AGENT AGAINST CLOSTRIDIUM DIFFICILE | 2016-10-13 |
20160296571 | BACTERIOPHAGES AGAINST SALMONELLA SSP AND THEIR USE | 2016-10-13 |
20160296572 | CHIMERIC VSV VIRUS COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER | 2016-10-13 |
20160296573 | WEIGHT LOSS FORMULATIONS, METHODS, AND COMPOSITIONS BASED ON TRADITIONAL CHINESE MEDICINE | 2016-10-13 |
20160296574 | EPHEDRA ALATA EXTRACTS AND METHODS OF USE THEREOF | 2016-10-13 |
20160296575 | Method for Manufacturing an extract of Rhinacanthus nasutus (L.) Kurz | 2016-10-13 |
20160296576 | TOPICAL MEDICATIONS FOR BRUISES AND BURNS | 2016-10-13 |
20160296577 | HERBAL COMPOSITION, PROCESS FOR ITS PREPARATION AND USE THEREOF | 2016-10-13 |
20160296578 | COMPOSITION AND METHOD FOR CONTROL OF POST-PRANDIAL GLUCOSE | 2016-10-13 |
20160296579 | CAPSULE CONTAINING TOTAL FLAVONOIDS OF DESMODIUM STYRACIFOLIUM, METHOD FOR PREPARING THE SAME AND USE | 2016-10-13 |
20160296580 | COMPOSITION FOR IMPROVING LACTATION | 2016-10-13 |
20160296581 | EXTRACTS OF ROSEMARY OR HEMEROCALLIS FULVA AND METHODS OF USING SAME TO PROMOTE CIRCADIAN RHYTHM | 2016-10-13 |
20160296582 | Mixture of Specific Essential Oils for the treatment of arthritis | 2016-10-13 |
20160296583 | METHODS AND COMPOUNDS FOR INTENSIVE SKIN REPAIR AND HEALING INCLUDING ACTIVE ORGANIC AND SYNTHETIC COMPOUNDS | 2016-10-13 |
20160296584 | TOPICAL COMPOSITIONS AND METHODS FOR ALLEVIATING OR INHIBITING SYMPTOMS ASSOCIATED WITH CARPAL TUNNEL SYNDROME, ACID REFLUX, PSORIASIS, CARTILAGE NODULES, FIBROMYALGIA, AND DIABETES | 2016-10-13 |
20160296585 | INFANT NUTRITION FOR IMPROVEMENT IN INSULIN SENSITIVITY LATER IN LIFE | 2016-10-13 |
20160296586 | AGENT FOR PREVENTING OR AMELIORATING VASCULAR ENDOTHELIAL MALFUNCTION | 2016-10-13 |
20160296587 | THERAPIES FOR LEFT VENTRICULAR NON-COMPACTION AND DILATED CARDIOMYOPATHY | 2016-10-13 |
20160296588 | CXCR ANTAGONISTIC PEPTIDES AND USES THEREOF | 2016-10-13 |
20160296589 | COMPOSITIONS AND METHODS FOR TREATING VITILIGO | 2016-10-13 |
20160296590 | METHOD OF TREATING OR PREVENTING EPILEPSY OR SEIZURES USING ONE OR MORE NEURAL REGENERATION PEPTIDES | 2016-10-13 |
20160296591 | COMPOSITIONS AND METHODS FOR TREATMENT OF BDNF-RELATED CONDITIONS | 2016-10-13 |
20160296592 | Methods and Compositions for the Treatment of Proteinuric Diseases | 2016-10-13 |
20160296593 | NOVEL FAT ACCUMULATION INHIBITORY PEPTIDE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OBESITY CONTAINING THE SAME | 2016-10-13 |
20160296594 | ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF | 2016-10-13 |
20160296595 | A RHO GTPASE ACTIVATOR FOR USE AS ANTIMICROBIAL AGENT | 2016-10-13 |
20160296596 | COMPOSITION FOR PREVENTION AND TREATMENT OF ALLERGIC AND/OR INFLAMMATORY DISEASES | 2016-10-13 |
20160296597 | TREATMENT OF CANCER | 2016-10-13 |